Our patient had severe eosinophilia, thrombocytopenia, and thrombosis so we evaluated him for underlying primary HES by sending the FIP1L1–PDGFRA fusion gene, PDGFRB JAK2V617F mutation, CALR, and BCR‐ABL mutation. The gene discussed is ABL1; the disease is hypereosinophilic syndrome.